SIOPEL 6: A multicenter open-label randomized phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard-risk hepatoblastoma (SR-HB)
- Resource Type
- Source
- Journal of Clinical Oncology. 32:TPS10094-TPS10094
- Subject
Cisplatin Cancer Research medicine.medical_specialty Hepatoblastoma business.industry medicine.disease Gastroenterology Surgery Oncology Ototoxicity Standard Risk Internal medicine medicine In patient Open label business medicine.drug - Language
- ISSN
- 1527-7755
0732-183X